MedPath

Electronic Neurocognitive Tools in Screening for Mental Capability in Patients Undergoing Liver Surgery

Not Applicable
Active, not recruiting
Conditions
Liver and Intrahepatic Bile Duct Disorder
Interventions
Behavioral: BrainCheck Cognitive Assessment
Procedure: Cognitive Assessment
Registration Number
NCT03678441
Lead Sponsor
M.D. Anderson Cancer Center
Brief Summary

This trial studies how well electronic neurocognitive tools work in screening for mental capability in patients who are undergoing liver surgery. Using electronic neurocognitive screening tools may help to better assess mental impairment.

Detailed Description

PRIMARY OBJECTIVES:

I. Evaluate feasibility of the electronic batteries, measured by the completion rate and time to completion of the batteries.

SECONDARY OBJECTIVES:

I. Comparison of the completion rate and time to completion between the written and electronic batteries.

II. Comparison of the scoring distribution between the screening tools.

EXPLORATORY OBJECTIVES:

I. Assess if a history of mental or cognitive illness or ongoing treatment with neuropsychiatric medications impact the ability to complete written and/or electronic neurocognitive screening.

OUTLINE: Patients are randomized to 1 of 2 groups.

GROUP I: Patients receive the BrainCheck cognitive assessment over 15 minutes followed by the paper and pen cognitive assessment within 2 months prior to surgery and within 2 months after surgery.

GROUP II: Patients receive the paper and pen cognitive assessment followed by the BrainCheck cognitive assessment over 15 minutes 2 months prior to surgery and within 2 months after surgery.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • All English-speaking patients undergoing hepatectomy at main campus University of Texas (UT)-MD Anderson Cancer Center who are cognitively able to provide informed consent in the opinion of the attending physician.
Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group I (BrainCheck and paper and pen cognitive assessment)BrainCheck Cognitive AssessmentPatients receive the BrainCheck cognitive assessment over 15 minutes followed by the paper and pen assessment 2 months prior to surgery and within 2 months after surgery.
Group I (BrainCheck and paper and pen cognitive assessment)Cognitive AssessmentPatients receive the BrainCheck cognitive assessment over 15 minutes followed by the paper and pen assessment 2 months prior to surgery and within 2 months after surgery.
Group II (pen and paper and BrainCheck cognitive assessment)BrainCheck Cognitive AssessmentPatients receive the paper and pen assessment followed by the BrainCheck cognitive assessment over 15 minutes 2 months prior to surgery and within 2 months after surgery.
Group II (pen and paper and BrainCheck cognitive assessment)Cognitive AssessmentPatients receive the paper and pen assessment followed by the BrainCheck cognitive assessment over 15 minutes 2 months prior to surgery and within 2 months after surgery.
Primary Outcome Measures
NameTimeMethod
Difference in score between the BrainCheck battery and the pen and paper assessmentsUp to 1 year

Will be calculated along with 95% CIs.

Average time to complete the pen and paper assessmentUp to 1 year

Will be calculated along with a 95% CI.

Difference in completion rate between the BrainCheck battery and paper and pen assessmentUp to 1 year

Will be calculated along with 95% CIs.

Difference in time to completion between the BrainCheck battery and the pen and paper assessmentUp to 1 year

Will be calculated along with 95% CIs.

Sensitivity, specificity, negative predictive value, positive predictive value, and accuracy of the electronic battery compared to the validated St. Louis University Mental Status Examination (SLUMS)Up to 1 year

Will be calculated along with 95% CIs.

Completion rate of the BrainCheck batteryUp to 1 year

Will be calculated along with a 95% confidence interval (CI).

Average time to complete the BrainCheck batteryUp to 1 year

Will be calculated along with a 95% CI.

Completion rate of the pen and paper assessmentUp to 1 year

Will be calculated along with a 95% CI.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

M D Anderson Cancer Center

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath